Not too far away now. I would say a few more months should see a positive announcement and more before end of calendar year.
I am confident our dossiers are quality and goid for approval. As I have said before, the FDA is super slow. Everybody has to deal with that.
- Forums
- ASX - By Stock
- Ann: Acrux's fourth generic dossier accepted by FDA for review
ACR
acrux limited
Add to My Watchlist
5.00%
!
1.9¢

Not too far away now. I would say a few more months should see a...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $13.72K | 687.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 10000 | 1 |
0.021 | 177000 | 1 |
0.022 | 27574 | 2 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 14.19pm 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online